News Quantified

GTHX – g1 therapeutics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.

G1 Therapeutics and Pepper Bio sign license agreement for lerociclib [Seeking Alpha]

G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights [Yahoo! Finance]

G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib [Yahoo! Finance]

2.7%

MISS

38.8%

BEAT

-18.8%

MISS

-4.9%

BEAT

Needham & Company LLC

Needham & Company LLC

Form 10-Q G1 Therapeutics, Inc. For: Mar 31

Form 8-K G1 Therapeutics, Inc. For: May 01

Form ARS G1 Therapeutics, Inc. For: Dec 31

Form DEFA14A G1 Therapeutics, Inc.

Form DEF 14A G1 Therapeutics, Inc. For: Jun 13

Top News Gainers

8/7 Form 8-K G1 Therapeutics, Inc. For: Aug 07 35.3%

6/18 G1 Therapeutics Announces Updated Results from Phase 2 Trial of Trilaciclib in Combination with Chemotherapy Showed Statistically Significant Improvement in Overall Survival in Women with Metastatic Triple-Negative Breast Cancer 24.1%

5/9 Q1/2019 3/31/2019 EPS -0.640 ZacksConsensus -0.690 ActVsEst 0.050 - Beat 20.9%

9/10 G1 Therapeutics to Present New Clinical Data Across Pipeline at European Society for Medical Oncology (ESMO) 2019 Congress 11.0%

12/17 G1 Therapeutics Inc (NASDAQ: GTHX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 9.6%

4/8 G1 Therapeutics Inc (NASDAQ: GTHX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $13.00 price target on the stock. 7.5%

6/18 G1 Therapeutics Inc (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at Cowen Inc. 7.2%

4/29 G1 Therapeutics to Provide First Quarter 2020 Corporate and Financial Update on May 6, 2020 6.4%

6/14 Form 4 G1 Therapeutics, Inc. For: Jun 12 Filed by: RUDNICK SETH 6.3%

4/24 Form DEF 14A G1 Therapeutics, Inc. For: Jun 11 6.2%

Top News Decliners

9/29 G1 Therapeutics Presents First Clinical Data on Oral SERD G1T48 Demonstrating Safety and Tolerability in Patients with Advanced Breast Cancer at ESMO 2019 -32.9%

3/13 Form 3 G1 Therapeutics, Inc. For: Mar 12 Filed by: Bailey John E. (Jack) Jr. -27.2%

3/12 G1 Therapeutics Announces Appointment of New Board Member and Chief Commercial Officer -17.2%

3/18 G1 Therapeutics Inc (NASDAQ: GTHX) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -16.9%

5/7 G1 Therapeutics Inc (NASDAQ: GTHX) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -8.5%

5/10 Form 4 G1 Therapeutics, Inc. For: May 08 Filed by: Moses Jennifer K. -8.2%

7/30 Form 3 G1 Therapeutics, Inc. For: Jul 29 Filed by: Avagliano Mark -7.3%

12/27 G1 Therapeutics Inc (NASDAQ: GTHX) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -7.2%

4/3 G1 Therapeutics Inc (NASDAQ: GTHX) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -6.9%

4/7 G1 Therapeutics to Present at 19th Annual Needham Virtual Healthcare Conference on April 14, 2020 -6.1%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day